Evidence map›Paper›PMID 40491778›Full record

ArticleCytotechnology2025

Functional improvements in β-conglycinin by conjugation with pectin by the Maillard reaction.

Toshiki Takai, Hikaru Murai, Naoko Zushi, Taku Neagari, Iroha Tanabe, Manami Nishiyama, Tadashi Yoshida, Makoto Hattori

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Cytotechnology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Toshiki TakaiDepartment of Applied Biological Science, Tokyo University of Agriculture and Technology, 3-5-8 Saiwai-cho, Fuchu, Tokyo 183-8509 Japan.
Hikaru MuraiDepartment of Applied Biological Science, Tokyo University of Agriculture and Technology, 3-5-8 Saiwai-cho, Fuchu, Tokyo 183-8509 Japan.
Naoko ZushiDepartment of Applied Biological Science, Tokyo University of Agriculture and Technology, 3-5-8 Saiwai-cho, Fuchu, Tokyo 183-8509 Japan.
Taku NeagariDepartment of Applied Biological Science, Tokyo University of Agriculture and Technology, 3-5-8 Saiwai-cho, Fuchu, Tokyo 183-8509 Japan.
Iroha TanabeDepartment of Applied Biological Science, Tokyo University of Agriculture and Technology, 3-5-8 Saiwai-cho, Fuchu, Tokyo 183-8509 Japan.
Manami NishiyamaDepartment of Applied Biological Science, Tokyo University of Agriculture and Technology, 3-5-8 Saiwai-cho, Fuchu, Tokyo 183-8509 Japan.
Tadashi YoshidaDepartment of Applied Biological Science, Tokyo University of Agriculture and Technology, 3-5-8 Saiwai-cho, Fuchu, Tokyo 183-8509 Japan.
Makoto HattoriDepartment of Applied Biological Science, Tokyo University of Agriculture and Technology, 3-5-8 Saiwai-cho, Fuchu, Tokyo 183-8509 Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

β-Conglycinin was conjugated with pectin by the Maillard reaction to improve its emulsifying property and reduce its allergenicity. Low methoxy pectin (LMP) and high methoxy pectin (HMP) were conjugated with β-conglycinin. Reaction ratio of β-conglycinin and pectin was 1.0: 5.0 (weight ratio). The Maillard Reaction was conducted at 65 °C at 79% relative humidity for 5 days to prepare the β-conglycinin-LMP conjugate and 7 days to prepare the β-conglycinin-HMP conjugate. The β-conglycinin-pectin conjugates were purified by salting out with ammonium sulfate. Conjugation was confirmed by SDS-PAGE. The results of bicinchoninic acid (BCA) method and phenol sulfuric acid method showed that weight ratio of protein and saccharide of the β-conglycinin-LMP and β-conglycinin-HMP conjugates was 1:1.33 and 1:0.73 respectively. The result of

Indexed as

Emulsifying propertyProtein conjugationReduced antigenicityReduced immunogenicitySolubilityβ-conglycinin

Identifiers

PMID40491778
PMCPMC12145386

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.